Louis L. Pisters

18.5k total citations · 2 hit papers
299 papers, 12.3k citations indexed

About

Louis L. Pisters is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Louis L. Pisters has authored 299 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Pulmonary and Respiratory Medicine, 129 papers in Surgery and 53 papers in Rheumatology. Recurrent topics in Louis L. Pisters's work include Prostate Cancer Diagnosis and Treatment (121 papers), Prostate Cancer Treatment and Research (110 papers) and Bladder and Urothelial Cancer Treatments (55 papers). Louis L. Pisters is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (121 papers), Prostate Cancer Treatment and Research (110 papers) and Bladder and Urothelial Cancer Treatments (55 papers). Louis L. Pisters collaborates with scholars based in United States, Spain and Canada. Louis L. Pisters's co-authors include Andrew C. von Eschenbach, Philippe E. Spiess, Colin P. Dinney, Andrew K. Lee, Curtis A. Pettaway, Dan Leibovici, Patricia Troncoso, David A. Swanson, Ashish M. Kamat and Deborah A. Kuban and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Louis L. Pisters

289 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

2008 1.7k citations Louis L. Pisters, Deborah A. Kuban et al. profile →
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

2006 1.0k citations Philippe E. Spiess, Xuemei Wang et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louis L. Pisters United States	58	7.1k	4.5k	2.5k	1.9k	1.9k	299	12.3k
Robert Huddart United Kingdom	62	5.6k 0.8×	7.8k 1.7×	3.2k 1.3×	1.2k 0.6×	2.7k 1.4×	388	14.9k
Hans von der Maase Denmark	56	3.4k 0.5×	8.2k 1.8×	4.8k 1.9×	1.1k 0.6×	2.8k 1.5×	214	13.6k
Laurent Salomon France	66	7.6k 1.1×	5.0k 1.1×	1.3k 0.5×	2.2k 1.2×	1.6k 0.8×	616	16.8k
Markus Hohenfellner Germany	54	5.5k 0.8×	2.5k 0.6×	1.2k 0.5×	2.2k 1.2×	1.4k 0.8×	351	9.5k
Robert C. Flanigan United States	41	5.8k 0.8×	2.1k 0.5×	1.7k 0.7×	1.1k 0.5×	3.0k 1.6×	246	9.0k
Kathleen J. Propert United States	50	2.6k 0.4×	1.8k 0.4×	2.3k 0.9×	1.6k 0.9×	1.7k 0.9×	147	9.9k
Michael O. Koch United States	54	3.1k 0.4×	3.3k 0.7×	1.5k 0.6×	1.1k 0.6×	1.5k 0.8×	280	8.3k
Padraig Warde Canada	61	9.7k 1.4×	5.1k 1.2×	3.2k 1.3×	2.0k 1.0×	1.7k 0.9×	420	16.2k
Philippe E. Spiess United States	43	2.6k 0.4×	5.3k 1.2×	1.5k 0.6×	1.8k 0.9×	1.2k 0.6×	474	8.6k
Carl A. Olsson United States	52	5.5k 0.8×	2.3k 0.5×	1.4k 0.6×	2.2k 1.1×	2.2k 1.2×	236	9.8k

Countries citing papers authored by Louis L. Pisters

Since Specialization

Citations

This map shows the geographic impact of Louis L. Pisters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis L. Pisters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis L. Pisters more than expected).

Fields of papers citing papers by Louis L. Pisters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis L. Pisters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis L. Pisters. The network helps show where Louis L. Pisters may publish in the future.

Co-authorship network of co-authors of Louis L. Pisters

This figure shows the co-authorship network connecting the top 25 collaborators of Louis L. Pisters. A scholar is included among the top collaborators of Louis L. Pisters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis L. Pisters. Louis L. Pisters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johns, Andrew, Matthew T. Campbell, Ahmet Murat Aydın, et al.. (2024). Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. Journal of Clinical Medicine. 13(12). 3436–3436.

Dimitropoulos, Konstantinos, Louis L. Pisters, Christos N. Papandreou, et al.. (2023). The Impact of Enhanced Recovery after Surgery Protocol Implementationon Postoperative Pain Management in the Era of Opioid Crisis: The PostchemotherapyOpen RPLND Experience. Current Cancer Drug Targets. 23(11). 910–916. 2 indexed citations

Ranasinghe, Weranja, Daniel D. Shapiro, Miao Zhang, et al.. (2021). Optimizing the diagnosis and management of ductal prostate cancer. Nature Reviews Urology. 18(6). 337–358. 22 indexed citations

Subudhi, Sumit K., Luis M. Vence, Hao Zhao, et al.. (2020). Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer. Science Translational Medicine. 12(537). 116 indexed citations

Cox, Matthew G., Karen Basen‐Engquist, Cindy L. Carmack, et al.. (2017). Comparison of Internet and Telephone Interventions for Weight Loss Among Cancer Survivors: Randomized Controlled Trial and Feasibility Study. JMIR Cancer. 3(2). e16–e16. 15 indexed citations

Williams, Stephen B., John W. Davis, Xuemei Wang, et al.. (2015). Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clinical Genitourinary Cancer. 14(2). 130–138. 14 indexed citations

Ho, Philip Levy, Daniel Willis, Lianchun Xiao, et al.. (2015). Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urologic Oncology Seminars and Original Investigations. 34(2). 59.e1–59.e8. 54 indexed citations

Spiess, Philippe E., David A. Levy, Louis L. Pisters, & J. Stephen Jones. (2012). 675 FIVE YEAR OUTCOMES OF SALVAGE CRYOTHERAPY FOR LOCALLY RECURRENT PROSTATE UPDATE FROM THE COLD REGISTRY. The Journal of Urology. 187(4S). 1 indexed citations

Cohen, Lorenzo, Patricia A. Parker, Luis M. Vence, et al.. (2011). Presurgical Stress Management Improves Postoperative Immune Function in Men With Prostate Cancer Undergoing Radical Prostatectomy. Psychosomatic Medicine. 73(3). 218–225. 53 indexed citations

10.

Parker, Patricia A., Curtis A. Pettaway, Richard J. Babaian, et al.. (2009). The Effects of a Presurgical Stress Management Intervention for Men With Prostate Cancer Undergoing Radical Prostatectomy. Journal of Clinical Oncology. 27(19). 3169–3176. 65 indexed citations

11.

Rewcastle, John C., et al.. (2007). MP-18.26: Focal and nerve sparing cryoablation: results from the COLD registry. Urology. 70(3). 143–144. 1 indexed citations

12.

Sabichi, Anita L., Seth P. Lerner, E. Neely Atkinson, et al.. (2006). Phase III bladder cancer chemoprevention trial with fenretinide.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

13.

Spiess, Philippe E., Gordon Brown, Louis L. Pisters, et al.. (2006). Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen. Cancer. 107(7). 1503–1510. 19 indexed citations

14.

Spiess, Philippe E., Gordon Brown, Ping Liu, et al.. (2006). Recurrence Pattern and Proposed Surveillance Protocol Following Post-Chemotherapy Retroperitoneal Lymph Node Dissection. The Journal of Urology. 177(1). 131–138. 8 indexed citations

15.

Kamat, Ashish M., Samuel Huang, Carlos E. Bermejo, et al.. (2003). Total Pelvic Exenteration: Effective Palliation of Perineal Pain in Patients With Locally Recurrent Prostate Cancer. The Journal of Urology. 170(5). 1868–1871. 40 indexed citations

16.

Sweeney, Paul, Christopher G. Wood, Louis L. Pisters, et al.. (2003). Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urologic Oncology Seminars and Original Investigations. 21(5). 327–333. 73 indexed citations

17.

Rosser, Charles J., et al.. (2002). Biochemical Disease-Free Survival in Men Younger Than 60 Years With Prostate Cancer Treated With External Beam Radiation. The Journal of Urology. 536–541. 1 indexed citations

18.

Pisters, Louis L., Paul Perrotte, SHELLIE M. SCOTT, Graham Greene, & Andrew C. von Eschenbach. (1999). Patient Selection for Salvage Cryotherapy for Locally Recurrent Prostate Cancer After Radiation Therapy. Journal of Clinical Oncology. 17(8). 2514–2514. 45 indexed citations

19.

Zhau, H E, Louis L. Pisters, Catherine Hall, et al.. (1994). Biomarkers associated with prostate cancer progression.. PubMed. 19. 208–16. 27 indexed citations

20.

Pisters, Louis L. & R. Joseph Babaian. (1993). Status of early prostate cancer detection. 45(5). 389–396. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact